arrow_back Trending Legislation
Share share

COVID-19 Reimbursement and Reporting Quality Assurance: Approved Tests Only

New rules aim to ensure federal funds for COVID-19 testing and treatment are only disbursed when approved tests were used. This means government agencies will scrutinize reimbursement requests, and false reports will be penalized. The goal is to improve the accuracy of COVID-19 data and protect public funds.
Key points
Reimbursements for COVID-19 testing and treatment will only be granted if approved tests were used.
Federal agencies will review each reimbursement request, denying or recovering funds if the test was not approved.
Official COVID-19 case and death counts will be corrected to exclude data based on unapproved tests.
Knowingly reporting a false COVID-19 diagnosis will result in up to 10 years imprisonment and/or a fine.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To provide for quality assurance of COVID-19 reimbursements and reporting.
Print number: HR 311
Sponsor: Rep. Posey, Bill [R-FL-8]
Process start date: 2021-01-13
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about COVID-19 Reimbursement and Reporting Quality Assurance: Approved Tests Only

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 311.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-01-13.

What are the main provisions?

Key points include:

  • Reimbursements for COVID-19 testing and treatment will only be granted if approved tests were used.
  • Federal agencies will review each reimbursement request, denying or recovering funds if the test was not approved.
  • Official COVID-19 case and death counts will be corrected to exclude data based on unapproved tests.
  • Knowingly reporting a false COVID-19 diagnosis will result in up to 10 years imprisonment and/or a fine.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Posey, Bill [R-FL-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Analysis and Potential Impact of HR 311

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Courts and Law